15, 2025 Tripling the standard dose of semaglutide, a popular drug prescribed to treat obesity, led to significantly greater weight loss and associated metabolic benefits without increased risk of serious side effects, a multicenter clinical trial led by a UT Southwestern Medical Center researcher shows
2 Semaglutide significantly outperformed placebo on both blood sugar control and weight loss
Tan Q, Orsso CE, Deehan EC, Triador L, Field CJ, Tun HM, et al
Asilsoy, S., Bekem, O., Karaman, O., Uzuner, N., and Kavukcu, S
Thng qua nhiu c ch can thip vo chuyn ha v hot ng ca mt s enzyme
In the UK, retatrutide is only accessible through approved clinical trials